Management of failed stenting of the unprotected left main coronary artery

Alice Moroni1, Federico Marin2, Gabriele Venturi3

  • 1Clinical and Interventional Cardiology Department, IRCCS Policlinico San Donato, University of Milan, San Donato Milanese, Italy.

Insights

Stent failure after percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) disease presents unique challenges. This overview proposes an algorithm for managing ULMCA stent failure, emphasizing intracoronary imaging.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) is a common treatment for unprotected left main coronary artery (ULMCA) disease, particularly in patients unsuitable for surgery.
  • Stent failure after PCI, especially in the ULMCA, is associated with increased complexity and poorer clinical outcomes compared to de novo lesions.
  • Existing evidence on managing stent failure specifically within the ULMCA setting is limited.

Purpose of the Study:

  • To provide a comprehensive overview of stent failure in the context of ULMCA disease.
  • To propose a tailored management algorithm for ULMCA stent failure.
  • To highlight the role of intracoronary imaging in characterizing mechanisms and guiding treatment decisions.

Main Methods:

  • Review of current literature and clinical practices regarding ULMCA stent failure.
  • Analysis of intracoronary imaging findings in failed ULMCA stents.
  • Development of a decision-making algorithm for ULMCA stent failure management.

Main Results:

  • Stent failure in ULMCA poses significant clinical challenges due to anatomical complexity.
  • Intracoronary imaging is crucial for identifying specific mechanisms of stent failure (e.g., in-stent restenosis, stent thrombosis).
  • A structured approach incorporating imaging and tailored techniques can optimize treatment outcomes.

Conclusions:

  • Management of ULMCA stent failure requires specialized consideration beyond standard PCI.
  • The proposed algorithm aims to standardize and improve decision-making for complex ULMCA stent failure cases.
  • Intracoronary imaging provides essential insights for effective intervention in failed ULMCA stents.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
18
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
41
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
15